Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,901 to 1,920 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity. | Cells | 2022 | 36010686 | PubTator, text mining | PubMed |
| An Epigenetic Role of Mitochondria in Cancer. | Cells | 2022 | 36010594 | PubTator, text mining | PubMed |
| Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias. | Biomedicines | 2022 | 36009388 | PubTator, text mining | PubMed |
| Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases. | Biomolecules | 2022 | 36009052 | PubTator, text mining | PubMed |
| Role of Caspase Family in Intervertebral Disc Degeneration and Its Therapeutic Prospects. | Biomolecules | 2022 | 36008968 | PubTator, text mining | PubMed |
| Multifaceted Roles of the N6-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment. | Biomolecules | 2022 | 36008936 | PubTator, text mining | PubMed |
| Predicting genes associated with RNA methylation pathways using machine learning. | Commun Biol | 2022 | 36008532 | PubTator, text mining | PubMed |
| Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer. | Front Oncol | 2022 | 36003776 | PubTator, text mining | PubMed |
| N6-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma. | Front Immunol | 2022 | 36003405 | PubTator, text mining | PubMed |
| RNA binding proteins in osteoarthritis. | Front Cell Dev Biol | 2022 | 36003144 | PubTator, text mining | PubMed |
| Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia. | Biomark Res | 2022 | 35999621 | PubTator, text mining | PubMed |
| Race-associated molecular changes in gynecologic malignancies. | Cancer Res Commun | 2022 | 35992327 | PubTator, text mining | PubMed |
| Construction of a survival nomogram for gastric cancer based on the cancer genome atlas of m6A-related genes. | Front Genet | 2022 | 35991573 | PubTator, text mining | PubMed |
| Identification and Validation of an Immune Evasion Molecular Subgroup of Patients With Colon Cancer for Implications of Immunotherapy. | Front Genet | 2022 | 35991554 | PubTator, text mining | PubMed |
| Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases. | Mol Ther Nucleic Acids | 2022 | 35991314 | PubTator, text mining | PubMed |
| m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer. | J Immunol Res | 2022 | 35991123 | PubTator, text mining | PubMed |
| Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke. | Front Cell Neurosci | 2022 | 35990887 | PubTator, text mining | PubMed |
| METTL1 gene polymorphisms synergistically confer hepatoblastoma susceptibility. | Discov Oncol | 2022 | 35986847 | PubTator, text mining | PubMed |
| Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA. | Mol Cancer | 2022 | 35986274 | PubTator, text mining | PubMed |
| Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials. | Int J Biol Sci | 2022 | 35982902 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=96